In This Section      
Print This Page

A Message for Our Valued Oncology Patients

We are proud to announce that as of 1 Nov 2017, oncology services, physicians and nurses will transition to Tan Tock Seng Hospital (“TTSH”), a member of the National Healthcare Group.

Read more

 

Clinical Trials in Singapore

Johns Hopkins Singapore is committed to finding new and effective treatments for all patients with cancer via our clinical trial programs.

All clinical trials at Johns Hopkins Singapore are carried out after obtaining relevant approval from the Health Sciences Authority of Singapore, our local Domain Specific Review Board and Clinical Research Review, and the Monitoring Committee of the Johns Hopkins Kimmel Cancer Center in Baltimore, Md.

Johns Hopkins Singapore is part of the Cancer Therapeutics Research Group, a joint research group that includes the National University Health System of Singapore; the Sydney Cancer Centre in Sydney, Australia; the Chinese University of Hong Kong; the National Cancer Centre Singapore; Singapore General Hospital; the Yonsei Cancer Center in Seoul, South Korea; the National Taiwan University Hospital; and the Sir Charles Gairdner Hospital in Perth, Australia.

The Cancer Therapeutics Research Group performs clinical trials on new anticancer drugs in the Asia-Pacific region.

Ongoing Clinical Trials at Johns Hopkins Singapore

Please click here for more information on the list of clinical trials that are currently open for enrollment.

All parties interested in participating in a clinical trial at Johns Hopkins Singapore are welcome to email us at trial@imc.jhmi.edu.